Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Healtheon Corporation (HLTH) -- Ignore unavailable to you. Want to Upgrade?

To: Ditchdigger who wrote (504)	3/16/2000 7:48:00 PM
From: Patriarch	Respond to of 861

Healtheon inks deal with Kiva for genomics channel ATLANTA, March 16 (Reuters) - Internet healthcare company Healtheon/WebMD Corp. (NasdaqNM:HLTH - news) said Thursday it has formed a $35 million, five-year partnership with privately held genetic research provider Kiva Genetics. Under the terms of the deal, Healtheon/WebMD will receive $35 million over five years from Kiva to deliver content to its WebMD (http://www.webmd.com) professional and consumer portals, and Healtheon/WebMD will make an equity investment in Kiva Genetics. The two companies will share revenues generated by the genetics and genomics channels. Shares of Healtheon/WebMD slipped 1-5/8 to 32-1/2 in early afternoon Nasdaq trading. Through this deal, Healtheon/WebMD will promote and market the genetics and genomics channels through online and offline advertising. Mountain View, Calif.-based Kiva Genetics said it will provide medically reviewed original content to the sites. Kiva will also provide access to genetics and genomics experts for live online chats. Healtheon/WebMD, which has been actively adding to its roster of partnerships in an attempt to be a key online link connecting doctors, patients and insurance companies, has been beefing up the WebMD side of the business. It recently added an integrative medicine channel. Integrative medicine is the clinical practice of integrating alternative therapies with conventional medicine.